Synvista Therapeutics, Inc.
SYNI
$0.00
$0.000.00%
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Net Income | 34.20% | 44.54% | 32.37% | -173.01% | 68.99% |
| Total Depreciation and Amortization | -3.03% | 101.37% | -98.81% | -74.11% | -72.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -27.90% | 710.98% | 245.30% | 433.78% | -97.77% |
| Change in Net Operating Assets | 232.31% | -95.48% | -206.26% | 897.09% | 121.53% |
| Cash from Operations | 17.20% | -35.09% | -61.43% | -68.26% | 24.47% |
| Capital Expenditure | -540.00% | -105.26% | 57.84% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | 33.23% |
| Cash from Investing | 97.61% | -105.26% | 57.84% | -102.40% | 32.98% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | 1,199.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -114.96% | -353.31% | -671.31% | -99.12% | 634.79% |
